Before Covid-19 | During Covid-19 | Test value | P-value | |
---|---|---|---|---|
No. = 42 | No. = 42 | |||
Weight z-score | ||||
Median (IQR) | -0.3 (-0.75–0.67) | -0.31 (-0.79–0.61) | -0.131c | 0.896 |
Range | -1.45–2.26 | -1.5–2.28 | ||
Height z-score | ||||
Median (IQR) | 0.1 (-0.77–0.53) | 0.04 (-0.82–0.52) | -1.857c | 0.063 |
Range | -2.59–2.35 | -2.3–2.31 | ||
BMI z-score | ||||
Median (IQR) | -0.03 (-0.69–0.69) | -0.19 (-0.62–0.64) | -1.369c | 0.171 |
Range | -2.51–2.54 | -2.49–2.89 | ||
Insulin dose (unit/Kg/day) | ||||
Mean ± SD | 0.83 ± 0.28 | 0.88 ± 0.30 | 3.757b | 0.001 |
Range | 0.5–1.7 | 0.5–1.8 | ||
Basal percentage (%) | ||||
Mean ± SD | 51.19 ± 3.46 | 52.74 ± 4.31 | 2.680b | 0.011 |
Range | 45–60 | 50–60 | ||
ICR | ||||
Median (IQR) | 15 (10–20) | 15 (10–20) | -1.300c | 0.194 |
Range | 8–30 | 8–50 | ||
ISF | ||||
Median (IQR) | 57.5 (40–90) | 52.5 (40–80) | -0.052c | 0.959 |
Range | 20–150 | 20–150 | ||
Insulin pump problems | ||||
Negative | 17 (40.5%) | 13 (31.0%) | 0.830a | 0.362 |
Positive | 25 (59.5%) | 29 (69.0%) | ||
DKA /year | ||||
Positive | 21 (50%) | 6 (14.3%) | 12.104c | 0.007 |
Frequency of hypoglycemia/ week | ||||
Median (IQR) | 3 (3–3) | 3 (2–3) | -2.858a | 0.004 |
Range | 0–7 | 0–7 | ||
Frequency of nocturnal hypoglycemia/ week | ||||
Median (IQR) | 2 (2–4) | 2 (1–3) | 1.340 | 0.180 |
Range | 1–5 | 1–4 | ||
Time above range (%) | ||||
Median (IQR) | 41 (31–47) | 39 (30.5–45) | 0.506c | 0.613 |
Range | 13–75 | 10–86 | ||
< 25 | 6 (14.3%) | 8 (19.0%) | 0.343a | 0.558 |
≥ 25 | 36 (85.7%) | 34 (81.0%) | ||
Time in range (%) | ||||
Median (IQR) | 53 (47–61) | 57.0 (51–73) | 2.105c | 0.035 |
Range | 19–83 | 12–80 | ||
< 70 | 35 (83.3%) | 24 (57.1%) | 6.891a | 0.009 |
≥ 70 | 7 (16.7%) | 18 (42.9%) | ||
Time below range (%) | ||||
Median (IQR) | 6 (2–8) | 3 (1–11) | 0.330c | 0.742 |
Range | 0–24 | 0–16 | ||
< 5 | 18 (42.9%) | 18 (42.9%) | 0.000a | 1.000 |
≥ 5 | 24 (57.1%) | 24 (57.1%) | ||
Coefficient of variation (%) | ||||
Mean ± SD | 42.10 ± 9.90 | 38.20 ± 8.12 | -2.174b | 0.036 |
Range | 20.3–77.4 | 23.3–54.4 | ||
< 36 | 8 (19.0%) | 22 (47.6%) | 10.163a | 0.001 |
≥ 36 | 34 (81.0%) | 20 (52.4%) | ||
HbA1C (mg/dl) | ||||
Mean ± SD | 8.8 ± 1.3 | 7.8 ± 1.2 | 4.263b | 0.001 |
Range | 6–11.5 | 4.9–11.3 | ||
HbA1C (mmol/mol) | ||||
Mean ± SD | 72.31 ± 16.78 | 61.31 ± 16.62 | ||
Range | 42– 102 | 30–100 |